Type 1 Diabetes
Type 1 Diabetes is a chronic condition where the pancreas produces little or no insulin, leading to high blood sugar levels. It often develops in children and young adults, requiring lifelong management.
Type 1 Diabetes: GZR33 Insulin Study
We are evaluating a new insulin called GZR33 to see how it compares to insulin Degludec in managing Type 1 Diabetes. The study focuses on its effectiveness, safety, and how the body processes it.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
PROFIL Institut fuer Stoffwechselforschung GmbH
Neuss, Germany
Sponsor: Gan & Lee Pharmaceuticals USA Corp.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.